Valneva SE (VALN) Debt Ratio (2020 - 2026)

Valneva SE's (VALN) quarterly Debt Ratio came in at 0.44 in Q1 2026, up 31.71% year-on-year from 0.33 in Q1 2025, and down 1.83% quarter-over-quarter from 0.45 in Q4 2025.

Valneva SE (VALN) Debt Ratio (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Debt Ratio across 7 years of filings, most recently posting 0.44 for Q1 2026.

  • Debt Ratio for Q1 2026 came in at 0.44, up 31.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.44 (up 31.71% YoY), and the FY2025 annual result was 0.45, up 19.88% from the prior year.
  • Debt Ratio came in at 0.44 for Q1 2026 at Valneva SE, down from 0.45 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.45 in Q4 2025 to a low of 0.06 in Q1 2022.
  • The 5-year median for Debt Ratio is 0.26 (2025), against an average of 0.26.
  • Across the five-year window, Debt Ratio surged 182.7% in 2024 and plunged 33.05% in 2025, its largest moves.
  • Valneva SE's Debt Ratio stood at 0.16 in 2022, then jumped by 141.73% to 0.38 in 2023, then retreated by 2.52% to 0.37 in 2024, then gained by 19.88% to 0.45 in 2025, then slipped by 1.83% to 0.44 in 2026.
  • The last three Debt Ratio figures came in at 0.44 (Q1 2026), 0.45 (Q4 2025), and 0.24 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.18
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 0.44

Historic Data

Download Data
DateValue
Mar 31, 2026 0.44
Dec 31, 2025 0.45
Sep 30, 2025 0.24
Jun 30, 2025 0.26
Mar 31, 2025 0.33
Dec 31, 2024 0.37
Sep 30, 2024 0.30
Jun 30, 2024 0.39
Mar 31, 2024 0.32
Dec 31, 2023 0.38
Sep 30, 2023 0.21
Jun 30, 2023 0.14
Mar 31, 2023 0.14
Dec 31, 2022 0.16
Sep 30, 2022 0.13
Jun 30, 2022 0.09
Mar 31, 2022 0.06
Dec 31, 2021 0.07
Dec 31, 2020 0.12